Pharmacia & Upjohn
This article was originally published in The Tan Sheet
Executive Summary
Nicorette sales were up 9.6% in 1999, totaling $233.6 mil., but declined 7.1% in the fourth quarter to $61.1 mil. due to strong year-ago sales that resulted from the introduction of the product's mint flavor. P&U directly sells the smoking cessation gum in various international markets and under a licensing agreement with SmithKline Beecham in the U.S. Firm's net sales increased 11.9% to $7.18 bil. for the year, while fourth quarter sales rose 9.7% to $1.94 bil. Net earnings - after adjusting for the acquisition of SUGEN, Inc. and various R&D charges - reached $944 mil. for the year, up 13.6%, and climbed 11.1% to $261 mil. in the quarter. The company announced Dec. 19 its plans to merge with Monsanto; the deal is expected to close in the first half of the year
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning